ConductScience.org, home
TRPV3: transient receptor potential cation channel subfamily V member 3
API referenceFor AI assistants

Gene · 162514

Papers1,367

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 1,367

Download this page as JSON
TitleJournalYearPMIDFound bySource
Targeting epidermal TRPV3 calcium channel alleviates psoriasis-like inflammation in vitro and in vivo.J Invest Dermatol202642785470PubTator, text miningPubMed
Avicularin and Senegenin Suppress TRPV3-Associated TSLP Expression in Human Keratinocytes.Cells202642782759PubTator, text miningPubMed
Pharmacological Activity of Motugivatrep, a Novel Antagonist of Transient Receptor Potential Cation Channel Subfamily V Member 1.Biol Pharm Bull202642749621PubTator, text miningPubMed
Successful Live Birth Following Treatment of Persistent Endometrial Dysbiosis and Recurrent Chronic Endometritis: A Case Report.Reprod Med Biol202642732330PubTator, text miningPubMed
Palmoplantar Keratoderma: A Mechanism-Based Disease Classification.Clin Cosmet Investig Dermatol202642725047PubTator, text miningPubMed
Tape Strip Transcriptomics Reveal Nemolizumab Effects on Pruritus, Hyperplasia, Inflammation, and Extracellular Matrix Markers in Patients With Moderate-to-Severe Atopic Dermatitis.Allergy202642693785PubTator, text miningPubMed
Transient receptor potential vanilloid channels in inflammatory bowel diseases: linking inflammation, angiogenesis, and oxidative stress.Inflammopharmacology202642507268PubTator, text miningPubMed
A non-covalently bound fluorescent probe with a larger fluorescence change for imaging Kv7 channels.Anal Chim Acta202642401463PubTator, text miningPubMed
Large-Scale Cohort Study on the Genetic and Phenotypic Findings of Palmoplantar Keratodermas in the Chinese Population.Exp Dermatol202642384829PubTator, text miningPubMed
Structural diversity of heat-sensing channel TRPV3 with Olmsted syndrome mutations.Nat Commun202642323291PubTator, text miningPubMed
TRPV3 facilitates metabolic alarmin-driven humoral immunity: from infection shielding to lupus flares.Cell Mol Immunol202642174142PubTator, text miningPubMed
Comprehensive Transcriptomic Profiling of Nonatopic Prurigo Nodularis in Korean Patients Reveals Il-22-driven Epidermal Stress and Neuro-immuno-fibrotic Remodelling.Acta Derm Venereol202642153310PubTator, text miningPubMed
Thermosensitive TRP channels as dietary modulators of adipose thermogenesis: Implications for energy homeostasis and obesity.J Therm Biol202642102493PubTator, text miningPubMed
Discovery of novel TRPV3 antagonists with o-hydroxybenzoic acid as the core skeleton.Eur J Med Chem202642019176PubTator, text miningPubMed
Channelopathies (Olmsted Syndrome)-causing point mutations of TRPV3 disrupt cellular thermal homeostasis in human keratinocytes.Life Sci202641932384PubTator, text miningPubMed
Association of erlotinib and acitretin for the treatment of Olmsted syndrome with erythromelalgia in a pediatric patient.An Bras Dermatol202641895212PubTator, text miningPubMed
Temperature-dependent gating pathways in TRPV3.Sci Rep202641882157PubTator, text miningPubMed
Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia.PLoS One202641880378PubTator, text miningPubMed
Monkeypox virus replication and host response in vaginal and ectocervical epithelial cells.Virulence202641880196PubTator, text miningPubMed
UVB Upregulates Inflammatory Cytokines in Rosacea Cell Model by Promoting the Expression of TRPVs and TLR2.Immunotargets Ther202641809119PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/162514/papers

API referenceFor AI assistants